1 / 30

Walgreen Co.

Walgreen Co. (WAG) Presented April 19, 2007. Investment Managers. Jessica Boghosian jboghos2@uiuc.edu Shengdong Zhu szhu4@uiuc.edu. Company Overview. Incorporated in 1909, headquartered in Deerfield, Illinois. Nation’s largest drugstore based on sales

jparnell
Download Presentation

Walgreen Co.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Walgreen Co. (WAG) Presented April 19, 2007

  2. Investment Managers • Jessica Boghosian • jboghos2@uiuc.edu • Shengdong Zhu • szhu4@uiuc.edu

  3. Company Overview • Incorporated in 1909, headquartered in Deerfield, Illinois. • Nation’s largest drugstore based on sales • Engaged in the retail sale of prescription and non-prescription drugs and general merchandise including: beauty care, personal care, household items, candy, photofinishing, greeting cards, seasonal items, and convenience foods. • Recorded its 32nd year of consecutive earnings and sales growth. • During the year, Walgreen Co. had a net increase of 476 stores, totaling to 5,461 stores located in 47 states and Puerto Rico.

  4. Company Overview • Success is dependent upon continuously opening new Walgreens stores. • Walgreen Co. plans to operate more than 7,000 stores by 2010. • Walgreen Co. is in the business of strategically locating new stores as well as relocating/closing existing stores.

  5. New Walgreens Co. Stores • Over the past 7 years, Walgreen Co. has opened on average 1.28 stores/day.

  6. National Store Distribution • Walgreen Co. has made it a point to open the most stores in the states that are the popular locations for aging baby boomers to retire. Image: Walgreen Co. Annual Report 2006

  7. Product Class Attribution to Sales

  8. Pharmacy Sales • Pharmacy sales continue to become a larger portion of Walgreens’ business. • Walgreens filled 529 million prescriptions in 2006, totaling to an increase of 8.1% from the 2005 fiscal year. • Sales trends are expected to continue to grow for the following reasons: • Aging population • Introduction of lower priced generics • Continued development of innovative drugs

  9. Medicare Part D • Medicare Part D is a government initiated program to subsidize the costs of prescription drugs to individuals covered by Medicare. Part D was implemented in January of 2006. • Walgreens has obtained a larger share of senior citizen patients due to this program. • 35% of the prescriptions filled under this program in the first eight months were new customers to Walgreens.

  10. New Developments • Dial-a-Pharmacist • Available in 14 languages, this system allows customers to discover where there is a Walgreens pharmacist that speaks his or her language. • Solar Power Usage • 100 stores utilize solar energy, making Walgreens the largest retail user of this source of energy. • Highway Signs • A new federal law allows signs to be placed on highways informing drivers of the location of 24 hour pharmacies. Several have already been planted with many more to come. Source: Walgreen Co. Annual Meeting, January 2006

  11. Corporate Risk • Walgreen Co. faces intense competition with local, regional, and national companies, many of which are infiltrating Walgreens’ existing markets. • Extreme competition can have an adverse affect on prices. • Third-party payors of prescription drugs are attempting to reduce costs and pharmacy reimbursement rates. • On February 8th, 2006, President Bush signed the Deficit Reduction Act of 2005 • This Act will ultimately reduce Medicaid reimbursement rates to retail pharmacies. • Further reduction in these rates are foreseeable.

  12. RCMP Position • Originally owned 1000 shares of WAG, purchases on October 6th, 1999 for $25.00/share. • On September 20th, 2006, 500 shares were sold @ $49.94/share for a realized gain of $12,470. • Currently own 500 shares of WAG, trading at $45.96 as of April 19, 2007 for an unrealized gain of $10,480 or 83.84%.

  13. Role in Portfolio • Walgreen Co. currently comprises 7% of our portfolio.

  14. Correlation Matrix

  15. 5-Year Growth vs. S&P 500

  16. Competitors • Who • CVS/Caremark Corp. (CVS) • Rite Aid Corp. (RAD) • Why • Industry Specific • Business Segment Specific (prescription and non-prescription drugs and general merchandise)

  17. Out-performing Its Competitors • Prescription Volume Source: Walgreen Co. Annual Meeting, January 2006

  18. Out-performing Its Competitors • Earnings per square foot Source: Walgreen Co. Annual Meeting, January 2006

  19. 1-Year Comparables

  20. 5-Year Comparables

  21. Comparable Analysis

  22. Assumptions • Organic growth continues to be the primary growth vehicle • Future growth was estimated assuming to be in line with increasing medical costs and increasing store numbers. • We assume that future growth will continue at a 13% annual rate but will gradually decrease to 9% over the next five years and then remain at a 3% annual growth rate thereafter

  23. Discounted Cash Flow Analysis

  24. Discounted Cash Flow Analysis • Since Walgreen Co. is 100% equity financed, WACC=ke. • Beta: Regression 0.1 vs. Bloomberg .66 • Average = .4

  25. Discounted Cash Flow Analysis

  26. A Note On Capital Structure • Walgreen Co. is an all equity financed firm. • The company owns a mere ~18% of it’s store base. The other ~82% is leased. • These leases hold Walgreen Co. responsible for $26.078 billion, but this obligation is not seen on the balance sheet as a liability to the firm. • This poses potentially risk to Walgreen Co. • Lets call these lease obligations “quasi-debt.” • THEREFORE, it is important to keep in mind this accounting structure when valuing WAG.

  27. Sensitivity Analysis Most likely to range from 34.73 to 57.04

  28. Portfolio Fit • Sharpe Ratio • a measure of the mean excess return per unit of risk in an investment asset or a trading strategy • Including WAG generates a higher Sharpe Ratio

  29. RCMP Fall ’06 Decision • 500 Shares of WAG were sold last semester at $49.94. Why? • Lease Obligations • WACC was adjusted upward based on the risk of outstanding lease obligations • After this adjustment, the company appeared to be trading at a “significantly inflated price that, in the long term, could not be sustained.”

  30. Recommendation • HOLD. • Why? • Healthy management vision • Stable, growing company • Solid performer • Leader in its class • But what about these lease obligations and other business risks!? • Acknowledge that every company has risk, with Wagreen Co. as no exception. • We have already taken action as conservative investors by selling 500 shares.

More Related